A high-lipid diet (HLD) may lead to adverse left ventricular (LV) remodeling and endothelial dysfunction in conditions of hemodynamic stress. Although congenital absence of nitric oxide synthase 3 (NOS3) leads to adverse LV remodeling after transverse aortic constriction (TAC), the effects of a HLD in this state remains unknown. Wild-type (WT) and NOS3 knockout mice (NOS3 2/2 ) were randomized into the following 4 groups: 1) WT + low-lipid diet (LLD) (10% of energy); 2)
Introduction
Obesity is an increasing public health concern associated with increased patient morbidity and mortality (1) . As the leading modifiable risk factor for the development of premature cardiovascular disease, obese individuals are at increased risk of developing hypertension, dyslipidemia, and impaired glucose tolerance (2) . Although chronic pressure overload due to hypertension may lead to adverse left ventricular (LV) 9 remodeling and heart failure in obese individuals, consumption of a high-lipid diet (HLD) may exacerbate this condition (3) .
Despite the increasing prevalence of heart failure, many of the mechanisms associated with its pathophysiologic development remain undetermined. One area of promise is the role of nitric oxide (NO) in heart failure. NO plays a cardioprotective role in LV remodeling through its endothelial-dependent vasodilation and antiatherogenesis effects (4) (5) (6) (7) (8) (9) (10) . NO is produced from the conversion of L-arginine to L-citrulline by 3 separate isoform enzymes, NO synthase (NOS)1 (neuronal NOS), NOS2 (inducible NOS), and NOS3 (endothelial NOS) (11) . Because NOS3 is constitutively expressed both in cardiac tissue and the vascular endothelium (12) , this isoform may play an important cardiovascular role in the setting of diet-induced obesity.
A growing body of evidence suggests that NOS3 plays a major protective role in LV remodeling after pressure overload induced by transverse aortic constriction (TAC) (13) (14) (15) . Previous studies have demonstrated increased LV systolic dysfunction and cardiac fibrosis in systemic NOS3-deficient (NOS3 2/2 ) mice compared with wild-type (WT) mice in a murine model of chronic pressure overload induced by TAC (13) (14) (15) . Whether a HLD may potentiate LV systolic dysfunction in NOS3 2/2 mice post-TAC remains ill defined.
Our aim in this study was to determine whether a HLD exacerbates LV systolic failure in NOS3 2/2 mice post-TAC. We compared the LV remodeling response to TAC in WT and NOS3 2/2 mice fed either a low-lipid diet (LLD) or the HLD, respectively.
Methods
Experimental mice. All animal procedures were conducted in accordance with guidelines published by the Canadian Council on Animal Care and the Guide for the Care and Use of Laboratory Animals published by the U.S. NIH.
Mice with targeted disruption of the NOS3 gene (NOS3 2/2 ) (Jackson Laboratory) were back-crossed to the C57Bl/6 background for a total of 8 generations. In total, 55 C57Bl/6 WT and 55 NOS3 2/2 male mice (6-8 wk old) were randomly assigned to 4 groups: 1) WT + LLD; 2) WT + HLD; 3) NOS3 2/2 + LLD; or 4) NOS3 2/2 + HLD. The LLD contained 10% of energy from fat [no. D12450B, Research Diets; previously described in (16) ] and the HLD contained 60% of energy from fat [no. D12492, Research Diets; previously described in (17) ]. The LLD contained 20 g (2% of total diet) of lard and the HLD contained 245 g (32% of total diet) of lard. One week after randomization into each diet, the mice underwent TAC as described below. Following TAC, the mice continued to consume the diets for a total of 12 wk.
Blood collection. One week prior to TAC and just prior to being killed, the mice were feed-deprived for a 12-h period and blood was collected from the jugular vein under light anesthesia. Plasma was separated and used for determination of total cholesterol (TC), triglyceride (TG), and glucose concentrations, as previously described (18) .
TAC. TAC was performed as previously described following 1 wk of consuming the LLD or HLD (13) .
Blood pressure measurements. Systolic blood pressure was measured noninvasively using a tail-cuff method on conscious, restrained mice using the CODA 6 system (Kent Scientific) at 2 wk following TAC, as previously described (19) .
Murine echocardiography. Murine transthoracic echocardiography was performed using a 13-MHz probe (Vivid 7, GE Medical Systems) in awake mice at baseline and monthly for a total of 3 mo as previously described (13) . Tissue Doppler imaging (TDI) was acquired on a parasternal short axis view at the level of the papillary muscles at a rate of 483 frames/s, as previously described (20) .
Histology. After macroscopic examination, the hearts were removed and fixed using 10% buffered formalin. Appropriate ventricular sections were cut and stained with hematoxylin and eosin, trichrome, and reticulin for pathological and morphometrical examinations based on our established methods (18) . All morphometric measurements were performed by 2 independent researchers who were unaware of group assignments. Microscopic evidence of LV hypertrophy (LVH) and perivascular fibrosis were analyzed semiquantitatively as previously described (18) .
Protein extraction and western blot analysis for fibroblast growth factor-2, transforming growth factor-bII, and Smad proteins. Tissue extracts were isolated as previously described (21) . Briefly, membranes, blocked in a Tris-buffered saline Tween-20 (TBS-T) solution containing 10% dried nonfat (skim) milk powder for a period of 1 h at room temperature, were rinsed and incubated with primary antibody [mouse anti-fibroblast growth factor-2 (FGF-2) from Millipore, 1:1000 dilution, or rabbit anti-pan-actin, from Sigma Aldrich, at 1:2000 dilution; mouse transforming growth factor 2 (TGFb-II), from Santa Cruz, 1:500 dilution; and mouse Smad 2 from Abcam; 1:1000 dilution] in 1% nonfat skim milk powder in TBS-T overnight at 48C with constant agitation. Antigen-antibody complexes were visualized by incubation with anti-mouse and anti-rabbit Ig conjugated to horseradish peroxidase, applied at 1:10,000 dilutions in TBS-T containing 1% skim milk, followed by the enzyme chemiluminescence plus kit according to the manufacturer's instructions.
Statistical analysis. All data are expressed as mean 6 SD. Significance between measurements was determined using a 2(diet) 3 2(genotype) 3 2(time) mixed factorial design with repeated measures on the time factor. For post hoc analysis, Tukey's multiple comparison test was used to test for significance between independent factors and Duncan's test was used to check for any significant differences within factors over time. In any post hoc between-group analysis, Levene's test was used to check for homogeneity of group variances. P-values for main effects and interactions were also recorded where appropriate. All tests were 2-sided and a P-value , 0.05 was considered significant. The statistical analysis packages SAS 9.01 (SAS Institute) and Statistica 6.1 (Statsoft) were used to perform the analysis.
Results

Murine echocardiography
At baseline, the LV cavity dimensions and systolic function were similar in the mice fed the WT + LLD, WT + HLD, NOS3
2/2 + LLD, and NOS3 2/2 + HLD diets ( Table 1) . There was evidence of LVH, with an increase in posterior wall thickness, in each of the 4 groups at 12 wk post-TAC compared with baseline (P , 0.05 for main effect of time) (Table 1) . At 12 wk post-TAC, the degree of LVH was similar among the 4 groups ( Table 1) . Echocardiographic analysis in each of the 4 groups also revealed an increase in LV end-diastolic diameter (LVEDD) at 12 wk post-TAC compared with baseline (P , 0.05 for main effect of time). Compared with the WT + LLD, WT + HLD, and NOS3 2/2 + LLD groups at 12 wk post-TAC, the LVEDD was greater in the NOS3 2/2 + HLD group (P , 0.05 for main effects of genotype and diet, respectively) ( Table 1) .
At baseline, the LV ejection fraction (LVEF) was similar in all 4 groups (Table 1) . Echocardiographic analysis in each of the 4 groups revealed a decrease in LVEF at 12 wk post-TAC compared with baseline (P , 0.05 for main effect of time). Compared with mice fed the WT + LLD, WT + HLD, and NOS3 2/2 + LLD diets at 12 wk post-TAC, the LVEF was lower in the NOS3 2/2 + HLD diet-fed group (P , 0.05 for main effects of G and D, respectively) ( Table 1) .
At baseline, TDI parameters were similar in all 4 groups ( Table 2) . Echocardiographic analysis in each of the 4 groups revealed a decrease in endocardial velocity and strain rate (SR) at 12 wk post-TAC compared with baseline (P , 0.05 for main effect of time). Compared with the WT + LLD, WT + HLD, and NOS3 2/2 + LLD diet-fed groups at 12 wk post-TAC, the SR was lower in the mice fed the NOS3 2/2 + HLD diet (P , 0.05 for main effects of G and D, respectively) ( Table 2 ).
Blood pressure measurements All 4 groups of mice were hypertensive 2 wk post-TAC, but the systolic blood pressure did not differ among the WT + LLD A high-lipid diet and nitric oxide synthase 3 deficiency 1439 (180 6 5 mm Hg), WT + HLD (186 6 3 mm Hg), NOS3
2/2 + LLD (184 6 2 mm Hg), and NOS3 2/2 + HLD (179 6 4 mm Hg) groups.
Body weight, LV weight, myocyte size, and myocardial fibrosis At baseline, body weight (20-22 g) did not differ in both genotypes of mice. Following 12 wk of the LLD, body weight increased by 30% (26-29 g) in both the WT and NOS3 2/2 mice. In mice fed the HLD, however, body weight increased by nearly 60% (32-35 g ) in the WT and NOS3 2/2 groups. There was no difference, however, in the LV:body weight ratio of all 4 groups at 12 wk post-TAC.
Representative cross-sections of myocardium from all 4 groups of mice demonstrated hypertrophy of cardiomyocytes at 12 wk post-TAC (Fig. 1) . There was a mild degree of LVH observed in WT and NOS3 2/2 mice fed the LLD (Fig. 1) . However, both the number of hypertrophic cells and the extent of their distribution in ventricular tissues was significantly higher in the NOS3 2/2 + HLD group (3.2 6 0.4) compared with the WT mice fed the same diet (1.6 6 0.3).
In general, there was an increase in intimal thickening due to smooth muscle proliferation in epicardial coronary arteries of NOS3 2/2 mice compared with the WT mice ( Fig. 1 ). This pathology was further exacerbated in the NOS3 2/2 + HLD group in which it was 3-fold greater (2.6 6 0.3) compared with 2/2 + HLD mice (P , 0.05 for main effects of G and D, respectively) ( Fig. 1) .
Plasma TC, TG, and glucose concentrations At baseline, plasma TC and TG concentrations did not differ among all 4 groups. In WT and NOS3 2/2 mice fed the LLD, TC increased by~100% at 12 wk post-TAC compared with baseline (P , 0.05 for main effect of time) ( Table 3) . Additionally, in the HLD stratum, TC concentrations increased by 1.5-fold in WT mice and 2.8-fold in NOS3 2/2 mice at 12 wk post-TAC compared with baseline (P , 0.05 for main effect of time) (Table 3) . Compared with the WT + LLD, WT + HLD, and NOS3 2/2 + LLD groups at 12 wk post-TAC, plasma TC concentrations were greater in the NOS3 2/2 + HLD mice (P , 0.05 for main effects of G and D, respectively).
Similarly to TC concentrations, TG concentrations increased in NOS3 2/2 mice fed either the LLD or the HLD, respectively (P , 0.05 for main effect of time) ( Table 3 ). The WT + LLD group did not show any significant increase in TG concentrations from baseline to 12 wk post-TAC (Table 3) . However, in the NOS3 2/2 + LLD group, TG increased by~100% from baseline to 12 wk post-TAC (P , 0.05 for main effect of time). In the NOS3 2/2 + HLD group, TG concentrations increased 2-fold at 12 wk post-TAC compared with baseline (P , 0.05 for main effect of time) (Table 3) . Compared with the WT + LLD, WT + HLD, and NOS3 2/2 + LLD groups at 12 wk post-TAC, plasma TG concentrations were greater in the NOS3 2/2 + HLD group (P , 0.05 for main effects of G and D, respectively).
Plasma glucose concentrations were measured in feeddeprived mice at baseline and 12 wk post-TAC. Concentrations increased 1.5-fold in each of the groups from baseline to wk 12, with no differences among the groups (data not shown).
Pro-hypertophic high molecular weight isoforms of FGF-2
High and low molecular weight FGF-2 Isoforms. At 12 wk post-TAC, the high molecular weight isoforms of FGF-2 (hi-FGF-2), recently implicated in the induction of myocardial hypertrophy, but not the low molecular weight isoform (lo-FGF-2), were significantly upregulated in LV lysates. Figure 2A is a representative western blot analysis of the LV cardiac lysates probed for total FGF-2. Figure 2B is the corresponding quantitative data. In NOS3 2/2 mice subjected to TAC, hi-FGF-2 increased greater than in their WT counterparts, irrespective of diet. Compared with the WT + LLD, WT + HLD, and NOS3 2/2 + LLD groups at 12 wk A high-lipid diet and nitric oxide synthase 3 deficiency 1441 post-TAC, hi-FGF-2 levels were greater in the NOS3 2/2 + HLD group (P , 0.05 for main effect of G).
TGF-bII and Smad protein analyses. At 12 wk post-TAC, there was no significant difference in either TGF-bII or Smad 2 protein expression among the 4 groups.
Discussion
In this study, we focused on the cardiovascular effects of a HLD in NOS3 2/2 mice subjected to TAC. A HLD is causal to the induction of cardiomyocyte hypertrophy and fibrosis, leading to adverse LV remodeling (21) , which may be exacerbated in conditions of hemodynamic stress such as chronic pressure overload. Before TAC, LV dimensions and contractile function did not differ between WT and NOS3 2/2 mice fed either the LLD or HLD, respectively. Three months after TAC, in vivo echocardiography demonstrated greater LV systolic dysfunction in the NOS3 2/2 + HLD group compared with the other groups. Mice in the NOS3 2/2 + HLD group demonstrated the greatest degree of LVH, pronounced interstitial fibrosis, hypercholesterolemia, and increased expression of hi-FGF-2 at 12 wk post-TAC.
At baseline, there were no significant differences between WT and NOS3 2/2 mice in echocardiographic parameters of LV cavity dimensions and systolic function. At 3 mo post-TAC, LV systolic dysfunction and remodeling was exacerbated in NOS3 2/2 mice compared with WT mice. Although both genotypes demonstrated systolic dysfunction as reflected by a decrease in both LVEF and TDI parameters, the NOS3 2/2 + HLD group demonstrated the worst cardiomyopathic features among all 4 groups. Our echocardiographic results of pronounced LV systolic dysfunction in the NOS3 2/2 mice post-TAC are in agreement with those of previous studies (13, 14) . Ruetten et al. (14) reported that abdominal aortic banding of WT and NOS3 2/2 mice for 6 wk increased LV wall thickness in NOS3 2/2 mice to a greater extent than in WT mice. Similar to our chronic pressure overload model, the morphological changes of LV were accompanied with both systolic and diastolic dysfunction in NOS3 2/2 mice. Furthermore, Ichinose et al. (13) reported an increase in LV cavity dimensions and a decrease in LVEF in NOS3 2/2 mice compared with WT mice post-TAC. Although LV systolic function was reduced in both groups, it was reduced to a greater extent in NOS3 2/2 mice than in WT mice (13) . Our study extends the previous observations that although NOS3
2/2 mice demonstrate adverse LV remodeling, compared with WT mice post-TAC, the degree of LV failure was further exacerbated by the HLD.
The effects of the HLD in the chronic pressure overload state are multifactorial, involving the fatty composition of the diet and the degree of hypertension due to TAC. Our results on the effects of a HLD on WT mice are similar to a recent study by Raher et al. (22) . Similar to our study, the WT + HLD (60% fat) group that underwent TAC using a 27-gauge needle demonstrated adverse LV remodeling at 1 mo of follow-up (22) . Our study contrasts, however, to the recently published study by Chess et al. (23), which did not demonstrate worsening LVH or LV systolic dysfunction in the WT + HLD group post-TAC. Although the degree of TAC using a 27-gauge needle was similar, the HLD consisted of only 45% fat in the study by Chess et al. (23) and the feeding was started after surgery. The higher degree of fat composition in our HLD and initiation of the diet 1 wk prior to TAC, similar to Raher et al. (22) , may account for the adverse LV remodeling observed in our studies.
In the current model, the degree of LVH on histological examination was found to be higher in NOS3 2/2 mice compared with WT mice. Cardiomyocyte hypertrophy was present in both genotypes fed either the LLD or the HLD. However, there was a greater degree of LVH in the NOS3 2/2 + LLD group than in the WT mice on a similar diet. Similarly, the NOS3 2/2 + HLD group had greater cardiomyocyte hypertrophy compared with WT mice fed a similar diet. Our findings are concordant with other models of chronic hypertension, demonstrating a greater degree of LVH in NOS3 2/2 mice (13, 14) . One potential mechanism for the difference in LVH in NOS3 2/2 mice compared with WT mice may involve FGF-2, which is a multifunctional, heparin-binding protein that regulates different physiologic processes, including angiogenesis, cell proliferation, differentiation, and migration (24) . It is expressed as 22-34 kDa hi-FGF-2 and 18 kDa lo-FGF-2 isoforms. In the current model, we demonstrated that prohypertrophic hi-FGF-2 (but not lo-FGF-2) was upregulated and was associated with different degrees of cardiac hypertrophy. From our findings, we determined that in the NOS3 2/2 + HLD group, hi-FGF-2 was greater than in their WT counterparts at 12 wk post-TAC. In fact, the NOS3 2/2 + HLD group demonstrated a greater increase in hi-FGF-2, even compared with the NOS3 2/2 + LLD group at 12 wk post-TAC.
Previous experiments have implicated FGF-2 in abdominal banding and angiotensin-II induced cardiac hypertrophy (25) . Additionally, in an acute rat model of myocardial infarction, accompanied by in vitro studies, Jiang et al. (26) demonstrated that hi-FGF-2 (but not lo-FGF-2) causes cardiac hypertrophy. The mechanism of how hi-FGF-2 leads to cardiac hypertrophy is not well known but may include stimulation of secretion of prohypertrophic cytokines from the cardiac nonmyocyte population (27) . It is hypothesized that hi-FGF-2 may stimulate transcription of prohypertrophic genes by directly translocating to the nucleus (24) (25) (26) (27) (28) . Our study is the first to our knowledge to assess the potential role of FGF-2 in the development of LVH in the NOS3 2/2 + HLD group post-TAC. In addition to LVH, the degree of interstitial fibrosis was enhanced in NOS3 2/2 mice compared with WT mice fed a similar diet. The degree of interstitial fibrosis around the coronary arteries was most pronounced in the NOS3 2/2 + HLD group, 12 wk post-TAC, compared with the other 3 groups. This further proves the deleterious role of a HLD in adverse LV remodeling in NOS3 2/2 mice in the setting of chronic pressure overload. Although our findings are in agreement with a previous study by Ruetten et al. (14) , who reported interstitial fibrosis in NOS3 2/2 mice subjected to abdominal aortic constriction as early as 6 wk post-TAC, our study extends the observation that a HLD potentiates the degree of adverse LV remodeling.
One potential mechanism that may contribute to the increased interstitial fibrosis observed in the NOS3 2/2 + HLD group in the chronic pressure overload state is the reninangiotensin system (RAS) (29) . There is considerable evidence in other models of NOS3 2/2 and chronic pressure overload that the RAS is inappropriately activated (29) (30) (31) (32) (33) . Chronic inhibition of NO by the NOS inhibitor L-NAME in rats activates the vascular and cardiac RAS, causing vascular thickening and perivascular and myocardial fibrosis (30) . In the current model, however, we did not demonstrate any difference in markers of the RAS, specifically TGF-bII or Smad 2 protein expression. This would suggest that the increased degree of interstitial fibrosis observed in the NOS3 2/2 + HLD group post-TAC is not entirely dependent on RAS activation.
In our current model of chronic pressure overload, metabolic abnormalities of dyslipidemia were exacerbated in the NOS3 2/2 + HLD group. Plasma TC and TG concentrations were increased in both WT and NOS3 2/2 mice 12 wk post-TAC compared with baseline. However, the NOS3 2/2 + HLD group had significantly higher concentrations of both TC and TG at 12 wk post-TAC compared with the WT + HLD group. Cardiomyocytes utilize mainly fatty acid derived from hydrolysis of TG circulating in the plasma. This process requires localization and activation of lipoprotein lipase in the cardiomyocytes (34) . An increase in the concentrations of TG in NOS3 2/2 mice may involve a direct effect of NO on either localization or activation of the lipoprotein lipase enzyme leading to increased concentrations of TG in the plasma of these mice (35) .
In summary, we established that the NOS3 2/2 + HLD group post-TAC demonstrated a greater degree of coronary intimal thickening, LVH, fibrosis, and LV systolic dysfunction. These findings suggest that the HLD may potentiate adverse cardiovascular remodeling in NOS3 2/2 mice in a chronic pressure overload state.
